Molecule intelOpportunity: ModerateEssentialCrowded market

Amlodipine

710 brands · 195 companies · product forms

ATC: C08CA01 2 DRAP alerts

Opportunity snapshot

Launch attractiveness
49
Market saturation
100
Price room
100
Regulatory risk
70
710
brands
195
companies
Rs 406.95
median price
876
price points
412.27x
price spread
100
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 3%

Price room

Across observed sources and strengths
CheapestRs 19
MedianRs 406.95
Most expensiveRs 7,833.04
Spread412.27×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 412.27x across 876 trusted points (Rs 19.0-7833.04). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 12 live products for Amlodipine — each links to its own medicine page.

Regulatory alerts

Recall exposurelatest 2026-01-14
131. Recall Alert (Class-II) – DTLs Punjab Declared Substandard products.
RECALL ALERT -TABLET AMLOshine (all strengths & batches) – Sunshine Pharmaceuticals

Why this score

Launch attractiveness

40% supply-gap(45) + 25% price-variation(100) + 20% low-competition(0) + 15% supply-disruption(40), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

195 canonical companies and 710 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 412.27x across 876 trusted points (Rs 19.0-7833.04). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

2 DRAP alert(s), latest 2026-01-14 incl. recall/safety.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.